-
1
-
-
0030265393
-
Vascular endothelial growth factor and its receptors
-
Klagsbrun M., and D'Amore P.A. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 7 (1996) 259-270
-
(1996)
Cytokine Growth Factor Rev
, vol.7
, pp. 259-270
-
-
Klagsbrun, M.1
D'Amore, P.A.2
-
2
-
-
33746851955
-
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
-
Thaker P.H., Han L.Y., Kamat A.A., et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12 (2006) 939-944
-
(2006)
Nat Med
, vol.12
, pp. 939-944
-
-
Thaker, P.H.1
Han, L.Y.2
Kamat, A.A.3
-
3
-
-
0037699954
-
The biology of VEGF and its receptors
-
Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
-
(2003)
Nat Med
, vol.9
, pp. 669-676
-
-
Ferrara, N.1
Gerber, H.P.2
LeCouter, J.3
-
4
-
-
0028803509
-
Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
-
Alon T., Hemo I., Itin A., Pe'er J., Stone J., and Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1 (1995) 1024-1028
-
(1995)
Nat Med
, vol.1
, pp. 1024-1028
-
-
Alon, T.1
Hemo, I.2
Itin, A.3
Pe'er, J.4
Stone, J.5
Keshet, E.6
-
5
-
-
19244379078
-
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
-
Carmeliet P., Moons L., Luttun A., et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7 (2001) 575-583
-
(2001)
Nat Med
, vol.7
, pp. 575-583
-
-
Carmeliet, P.1
Moons, L.2
Luttun, A.3
-
6
-
-
0029004025
-
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
-
Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146 (1995) 1029-1039
-
(1995)
Am J Pathol
, vol.146
, pp. 1029-1039
-
-
Dvorak, H.F.1
Brown, L.F.2
Detmar, M.3
Dvorak, A.M.4
-
7
-
-
0036793818
-
Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer
-
Cooper B.C., Ritchie J.M., Broghammer C.L., et al. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer. Clin Cancer Res 8 (2002) 3193-3197
-
(2002)
Clin Cancer Res
, vol.8
, pp. 3193-3197
-
-
Cooper, B.C.1
Ritchie, J.M.2
Broghammer, C.L.3
-
8
-
-
33751006991
-
Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer
-
Hefler L.A., Zeillinger R., Grimm C., et al. Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer. Gynecol Oncol 103 (2006) 512-517
-
(2006)
Gynecol Oncol
, vol.103
, pp. 512-517
-
-
Hefler, L.A.1
Zeillinger, R.2
Grimm, C.3
-
9
-
-
3242658330
-
Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer
-
Li L., Wang L., Zhang W., et al. Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer. Anticancer Res 24 (2004) 1973-1979
-
(2004)
Anticancer Res
, vol.24
, pp. 1973-1979
-
-
Li, L.1
Wang, L.2
Zhang, W.3
-
10
-
-
0030923795
-
Vascular endothelial growth factor expression in early stage ovarian carcinoma
-
Paley P.J., Staskus K.A., Gebhard K., et al. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 80 (1997) 98-106
-
(1997)
Cancer
, vol.80
, pp. 98-106
-
-
Paley, P.J.1
Staskus, K.A.2
Gebhard, K.3
-
11
-
-
33846933952
-
Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies
-
Frumovitz M., and Sood A.K. Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies. Gynecol Oncol 104 (2007) 768-778
-
(2007)
Gynecol Oncol
, vol.104
, pp. 768-778
-
-
Frumovitz, M.1
Sood, A.K.2
-
12
-
-
36849019301
-
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group study
-
Burger R., Sill M., Monk B., Greer B., and Sorosky J. Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group study. J Clin Oncol 25 (2007) 5165-5171
-
(2007)
J Clin Oncol
, vol.25
, pp. 5165-5171
-
-
Burger, R.1
Sill, M.2
Monk, B.3
Greer, B.4
Sorosky, J.5
-
13
-
-
2542561964
-
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
-
Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350 (2004) 2335-2342
-
(2004)
N Engl J Med
, vol.350
, pp. 2335-2342
-
-
Hurwitz, H.1
Fehrenbacher, L.2
Novotny, W.3
-
15
-
-
41349088227
-
Role of pericytes in angiogenesis
-
Teicher B.A., and Ellis L.M. (Eds), Humana Press, Inc, Totowa (NJ)
-
Lu C., and Sood A. Role of pericytes in angiogenesis. In: Teicher B.A., and Ellis L.M. (Eds). Angiogenesis agents in cancer therapy. 2nd ed. (2008), Humana Press, Inc, Totowa (NJ) 117-132
-
(2008)
Angiogenesis agents in cancer therapy. 2nd ed.
, pp. 117-132
-
-
Lu, C.1
Sood, A.2
-
16
-
-
0021152182
-
Pericyte endothelial gap junctions in human cerebral capillaries
-
(Berl)
-
Cuevas P., Gutierrez-Diaz J.A., Reimers D., Dujovny M., Diaz F.G., and Ausman J.I. Pericyte endothelial gap junctions in human cerebral capillaries. Anat Embryol 170 (1984) 155-159 (Berl)
-
(1984)
Anat Embryol
, vol.170
, pp. 155-159
-
-
Cuevas, P.1
Gutierrez-Diaz, J.A.2
Reimers, D.3
Dujovny, M.4
Diaz, F.G.5
Ausman, J.I.6
-
17
-
-
0016730816
-
Tridimensional views of the relationship of pericytes to endothelial cells of capillaries in the human choroid and retina
-
(Tokyo)
-
Matsusaka T. Tridimensional views of the relationship of pericytes to endothelial cells of capillaries in the human choroid and retina. J Electron Microsc 24 (1975) 13-18 (Tokyo)
-
(1975)
J Electron Microsc
, vol.24
, pp. 13-18
-
-
Matsusaka, T.1
-
18
-
-
0034648765
-
Angiogenesis in cancer and other diseases
-
Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
-
(2000)
Nature
, vol.407
, pp. 249-257
-
-
Carmeliet, P.1
Jain, R.K.2
-
19
-
-
0035972251
-
Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis
-
Hellstrom M., Gerhardt H., Kalen M., et al. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153 (2001) 543-553
-
(2001)
J Cell Biol
, vol.153
, pp. 543-553
-
-
Hellstrom, M.1
Gerhardt, H.2
Kalen, M.3
-
20
-
-
0038476608
-
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
-
Bergers G., Song S., Meyer-Morse N., Bergsland E., and Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111 (2003) 1287-1295
-
(2003)
J Clin Invest
, vol.111
, pp. 1287-1295
-
-
Bergers, G.1
Song, S.2
Meyer-Morse, N.3
Bergsland, E.4
Hanahan, D.5
-
21
-
-
34547100525
-
Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma
-
Lu C., Kamat A., Lin Y.G., et al. Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma. Clin Cancer Res 13 (2007) 4209-4217
-
(2007)
Clin Cancer Res
, vol.13
, pp. 4209-4217
-
-
Lu, C.1
Kamat, A.2
Lin, Y.G.3
-
22
-
-
0030756325
-
Pericyte loss and microaneurysm formation in PDGF-B-deficient mice
-
Lindahl P., Johansson B.R., Leveen P., and Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277 (1997) 242-245
-
(1997)
Science
, vol.277
, pp. 242-245
-
-
Lindahl, P.1
Johansson, B.R.2
Leveen, P.3
Betsholtz, C.4
-
23
-
-
0042125242
-
Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall
-
Lindblom P., Gerhardt H., Liebner S., et al. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev 17 (2003) 1835-1840
-
(2003)
Genes Dev
, vol.17
, pp. 1835-1840
-
-
Lindblom, P.1
Gerhardt, H.2
Liebner, S.3
-
24
-
-
14644446018
-
A multi-targeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is anti-angiogenic, producing objective responses and survival benefit in a mouse model of cancer
-
Pietras K., and Hanahan D. A multi-targeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is anti-angiogenic, producing objective responses and survival benefit in a mouse model of cancer. J Clin Oncol 23 (2005) 939-952
-
(2005)
J Clin Oncol
, vol.23
, pp. 939-952
-
-
Pietras, K.1
Hanahan, D.2
-
25
-
-
1042301958
-
Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma
-
Apte S.M., Fan D., Killion J.J., and Fidler I.J. Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma. Clin Cancer Res 10 (2004) 897-908
-
(2004)
Clin Cancer Res
, vol.10
, pp. 897-908
-
-
Apte, S.M.1
Fan, D.2
Killion, J.J.3
Fidler, I.J.4
-
26
-
-
0034989658
-
Developmental roles of platelet-derived growth factors
-
Betsholtz C., Karlsson L., and Lindahl P. Developmental roles of platelet-derived growth factors. Bioessays 23 (2001) 494-507
-
(2001)
Bioessays
, vol.23
, pp. 494-507
-
-
Betsholtz, C.1
Karlsson, L.2
Lindahl, P.3
-
27
-
-
0027936261
-
Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities
-
Leveen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E., and Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8 (1994) 1875-1887
-
(1994)
Genes Dev
, vol.8
, pp. 1875-1887
-
-
Leveen, P.1
Pekny, M.2
Gebre-Medhin, S.3
Swolin, B.4
Larsson, E.5
Betsholtz, C.6
-
28
-
-
27644479545
-
Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors
-
Thaker P.H., Yazici S., Nilsson M.B., et al. Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors. Clin Cancer Res 11 (2005) 4923-4933
-
(2005)
Clin Cancer Res
, vol.11
, pp. 4923-4933
-
-
Thaker, P.H.1
Yazici, S.2
Nilsson, M.B.3
-
29
-
-
0037567495
-
Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis
-
Langley R.R., Ramirez K.M., Tsan R.Z., Van Arsdall M., Nilsson M.B., and Fidler I.J. Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis. Cancer Res 63 (2003) 2971-2976
-
(2003)
Cancer Res
, vol.63
, pp. 2971-2976
-
-
Langley, R.R.1
Ramirez, K.M.2
Tsan, R.Z.3
Van Arsdall, M.4
Nilsson, M.B.5
Fidler, I.J.6
-
30
-
-
4644315256
-
Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion
-
Sood A.K., Coffin J.E., Schneider G.B., et al. Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. Am J Pathol 165 (2004) 1087-1095
-
(2004)
Am J Pathol
, vol.165
, pp. 1087-1095
-
-
Sood, A.K.1
Coffin, J.E.2
Schneider, G.B.3
-
31
-
-
31544465011
-
Stress hormone-mediated invasion of ovarian cancer cells
-
Sood A.K., Bhatty R., Kamat A.A., et al. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res 12 (2006) 369-375
-
(2006)
Clin Cancer Res
, vol.12
, pp. 369-375
-
-
Sood, A.K.1
Bhatty, R.2
Kamat, A.A.3
-
32
-
-
0035071510
-
Molecular determinants of ovarian cancer plasticity
-
Sood A.K., Seftor E.A., Fletcher M.S., et al. Molecular determinants of ovarian cancer plasticity. Am J Pathol 158 (2001) 1279-1288
-
(2001)
Am J Pathol
, vol.158
, pp. 1279-1288
-
-
Sood, A.K.1
Seftor, E.A.2
Fletcher, M.S.3
-
33
-
-
33947593200
-
-
American Cancer Society, Atlanta (GA)
-
Cancer facts and figures 2007 (2007), American Cancer Society, Atlanta (GA)
-
(2007)
Cancer facts and figures 2007
-
-
-
34
-
-
0141688377
-
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study
-
Ozols R.F., Bundy B.N., Greer B.E., et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 21 (2003) 3194-3200
-
(2003)
J Clin Oncol
, vol.21
, pp. 3194-3200
-
-
Ozols, R.F.1
Bundy, B.N.2
Greer, B.E.3
-
35
-
-
33644908789
-
Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment
-
Markman M., and Walker J.L. Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment. J Clin Oncol 24 (2006) 988-994
-
(2006)
J Clin Oncol
, vol.24
, pp. 988-994
-
-
Markman, M.1
Walker, J.L.2
-
36
-
-
0032952010
-
Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
-
Benjamin L.E., Golijanin D., Itin A., Pode D., and Keshet E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103 (1999) 159-165
-
(1999)
J Clin Invest
, vol.103
, pp. 159-165
-
-
Benjamin, L.E.1
Golijanin, D.2
Itin, A.3
Pode, D.4
Keshet, E.5
-
37
-
-
0035347301
-
Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival
-
Reinmuth N., Liu W., Jung Y.D., et al. Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J 15 (2001) 1239-1241
-
(2001)
FASEB J
, vol.15
, pp. 1239-1241
-
-
Reinmuth, N.1
Liu, W.2
Jung, Y.D.3
|